Andrew A. Hindman Insider Trading $TBPH Theravance Biopharma, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew A. Hindman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew A. Hindman. Andrew A. Hindman is Chief Business Dev. Officer in ACORDA THERAPEUTICS INC ($ACOR) and Chief Business Officer in ACORDA THERAPEUTICS INC ($ACOR) and SVP, Chief Financial Officer in Theravance Biopharma, Inc. ($TBPH).
Andrew A. Hindman in Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew A. Hindman: SVP, Chief Financial Officer
Holdings: 188,688 shares
Current Value: $5,773,853
Latest Transaction: Feb 10 2021
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Andrew A. Hindman in Theravance Biopharma, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10 2021 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 65,000 | 0 | 188,688 | 123.7 K to 188.7 K (+52.55 %) |
| Aug 24 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Payment of Exercise | F | 18.22 | 4,323 | 78,765 | 123,135 | 127.5 K to 123.1 K (-3.39 %) |
| Jul 29 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 20,000 | 0 | 127,458 | 107.5 K to 127.5 K (+18.61 %) |
| Feb 24 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Payment of Exercise | F | 25.90 | 7,060 | 182,854 | 106,490 | 113.6 K to 106.5 K (-6.22 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 20,000 | 0 | 113,550 | 93.6 K to 113.6 K (+21.38 %) |
| Feb 05 2020 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 43,550 | 0 | 93,550 | 50 K to 93.6 K (+87.10 %) |
| Jul 03 2019 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Option Exercise | A | 16.94 | 260,000 | 4,404,400 | 260,000 | |
| Jul 03 2019 | TBPH | Theravance Biophar ... | Hindman Andrew A. | SVP, Chief Financia ... | Grant | A | 0.00 | 50,000 | 0 | 50,000 | 0 to 50 K |
Page: 1